Marker Therapeutics, Inc.

Monthly Archives: July 2018

New Details Emerge on TapImmune Merger

TapImmune Inc., Jacksonville’s publicly traded developer of cancer-fighting immunotherapies, announced in May that it was merging with Minnesota-based Marker Therapeutics Inc., another developer of immunotherapies.

Read More

No Revenue, but TapImmune Leads Pack

Company developing immunotherapy treatments for cancer up 139 percent this year.

Read More